Marina J Santiago

发表

Interaction With the Lipid Membrane Influences Fentanyl Pharmacology

R. Sessions, S. Charlton, R. Corey, 2022, Advances in Drug and Alcohol Research.

Differential activation of G protein‐mediated signaling by synthetic cannabinoid receptor agonists

C. Bladen, M. Kassiou, M. Connor, 2019, bioRxiv.

Low intrinsic efficacy for G protein activation can explain the improved side effect profiles of new opioid agonists

J. R. Lane, M. Kassiou, S. Schulz, 2020, Science Signaling.

Cannabichromene is a cannabinoid CB2 receptor agonist

I. McGregor, M. Connor, Marina Santiago, 2018, bioRxiv.

Buprenorphine signalling is compromised at the N40D polymorphism of the human μ opioid receptor in vitro

M. Connor, Marina Santiago, A. Knapman, 2014, British journal of pharmacology.

Pharmacology of Valinate and tert-Leucinate Synthetic Cannabinoids 5F-AMBICA, 5F-AMB, 5F-ADB, AMB-FUBINACA, MDMB-FUBINACA, MDMB-CHMICA, and Their Analogues.

M. Glass, I. McGregor, M. Kassiou, 2016, ACS chemical neuroscience.

Inhibition of human recombinant T‐type calcium channels by phytocannabinoids in vitro

C. Bladen, M. Connor, J. Arnold, 2022, British journal of pharmacology.

Terpenoids Commonly Found in Cannabis sativa Do Not Modulate the Actions of Phytocannabinoids or Endocannabinoids on TRPA1 and TRPV1 Channels

I. McGregor, M. Connor, J. Arnold, 2020, Cannabis and cannabinoid research.

Absence of Entourage: Terpenoids Commonly Found in Cannabis sativa Do Not Modulate the Functional Activity of Δ9-THC at Human CB1 and CB2 Receptors

I. McGregor, M. Connor, J. Arnold, 2019, bioRxiv.